Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FIBROGEN INC Director's Dealing 2016

Dec 17, 2016

34576_dirs_2016-12-16_d7956005-b653-4d75-8528-4f497966787d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2016-12-16

Reporting Person: RIGGS RORY B (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-12-16 Common Stock S 20000 $20.8655 Disposed 460200 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 605713 Indirect

Footnotes

F1: The shares were sold at prices ranging from $20.7334 to $21.1466. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2: Shares are held by New Ventures I, LLC. The reporting person is Managing Member of New Ventures I, LLC and has voting and investment control with respect to the shares held by New Ventures I, LLC.